Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

DISC-0974, an Anti-Hemojuvelin Antibody, Reduces Hepcidin and Mobilizes Iron in Healthy Volunteers

Natasha Novikov, Akshay Buch, Hua Yang, Sarah Tuller, Michelle Andruk, Katherine Chan, Min Wu, Richard Rodriguez, Rajiv Panwar, Haley Howell, Brian MacDonald, Will Savage

Blood (2022) 140 (Supplement 1): 5339–5340.

https://doi.org/10.1182/blood-2022-167870

Published: 2022

Journal Articles

Preclinical Pharmacokinetics and Pharmacodynamics of DISC-0998, a Humanized Anti-Hemojuvelin (HJV) Monoclonal Antibody to Suppress the Production of Hepcidin

Yue Chen, Will Savage, Rajiv Panwar, Richard Rodriguez, Min Wu, John Quisel, Hua Yang

Blood (2022) 140 (Supplement 1): 8184–8185.

https://doi.org/10.1182/blood-2022-168985

Published: 2022

Journal Articles

The PI3K Delta Inhibitor TGR-1202 and Proteasome Inhibitor Carfilzomib Are Highly Synergistic In Killing Human B- and T-Cell Lymphoma Cells

Changchun Deng, M.D, PH.D., Christine McIntosh, Richard Rodriguez, B.S., Peter Sportelli, Hari P. Miskin, MS, Swaroop Vakkalanka, PhD, Srikant Viswanadha, Ph.D., Mark Lipstein, B.S., Owen A. O'Connor, MD, PhD

Blood (2013) 122 (21): 4421.

https://doi.org/10.1182/blood.V122.21.4421.4421

Published: 2013

Journal Articles

Combination Of Selective HDAC Inhibitors That Target Specific HDAC Isoforms Synergistically Inhibits T Cell Lymphoma

Changchun Deng, MD, PhD, Richard Rodriguez, B.S., Christine McIntosh, Edward Holson, PH.D., Charles Karan, PH.D., Mark Lipstein, B.S., Owen A. O'Connor, MD, PhD

Blood (2013) 122 (21): 5142.

https://doi.org/10.1182/blood.V122.21.5142.5142

Published: 2013

Journal Articles

Novel PI3K Inhibitors Demonstrated Marked Cytotoxicity in T Cell Lymphoma Models, Caused Apoptosis and Were Synergistic with A Novel Anti-CD20 Monoclonal Antibody Ublituximab in B Cell Lymphoma Models

Changchun Deng, MD, PHD, Peter Sportelli, Richard Rodriguez, Hari Miskin, Swaroop Vakkalanka, Srikant Viswanadha, Owen A. O'Connor, MD, PhD

Blood (2012) 120 (21): 3725.

https://doi.org/10.1182/blood.V120.21.3725.3725

Published: 2012

NARROW

DISC-0974, an Anti-Hemojuvelin Antibody, Reduces Hepcidin and Mobilizes Iron in Healthy Volunteers

Preclinical Pharmacokinetics and Pharmacodynamics of DISC-0998, a Humanized Anti-Hemojuvelin (HJV) Monoclonal Antibody to Suppress the Production of Hepcidin

The PI3K Delta Inhibitor TGR-1202 and Proteasome Inhibitor Carfilzomib Are Highly Synergistic In Killing Human B- and T-Cell Lymphoma Cells

Combination Of Selective HDAC Inhibitors That Target Specific HDAC Isoforms Synergistically Inhibits T Cell Lymphoma

Novel PI3K Inhibitors Demonstrated Marked Cytotoxicity in T Cell Lymphoma Models, Caused Apoptosis and Were Synergistic with A Novel Anti-CD20 Monoclonal Antibody Ublituximab in B Cell Lymphoma Models

Email alerts

ASH Publications

American Society of Hematology

DISC-0974, an Anti-Hemojuvelin Antibody, Reduces Hepcidin and Mobilizes Iron in Healthy Volunteers

Preclinical Pharmacokinetics and Pharmacodynamics of DISC-0998, a Humanized Anti-Hemojuvelin (HJV) Monoclonal Antibody to Suppress the Production of Hepcidin

The PI3K Delta Inhibitor TGR-1202 and Proteasome Inhibitor Carfilzomib Are Highly Synergistic In Killing Human B- and T-Cell Lymphoma Cells

Combination Of Selective HDAC Inhibitors That Target Specific HDAC Isoforms Synergistically Inhibits T Cell Lymphoma

Novel PI3K Inhibitors Demonstrated Marked Cytotoxicity in T Cell Lymphoma Models, Caused Apoptosis and Were Synergistic with A Novel Anti-CD20 Monoclonal Antibody Ublituximab in B Cell Lymphoma Models

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only